PIAS4 and cancer: However, contrary to PIAS1 and PIAS3, PIAS4 favors the survival of cancer cells, promoting the overexpression and stability of lysine demethylase 5B (KDM5B) in hypoxia through its sumoylation, thus provoking the inhibition of CDKN1A (P21) transcription [197].